Amin Khalifa - Avivagen Insider

Avivagen Inc -- Canada Stock  

CAD 0.95  0.05  5%

Independent Director

Mr. Amin I. Khalifa is Independent Director of Avivagen Inc. He was Oct 2010 to present CFO Corporationrationrate Vice President, Iris International Inc., January 2008 to September 2010 Principal Khalifa Management Consulting, August 2006 to September 2007 Executive Vice President CFO Leap Wireless, August 2003 to August 2006 Executive Vice President CFO Apria Healthcare.
  Director Since 2011      
613-949-8164  http://www.avivagen.com

Management Efficiency

The company has return on total asset (ROA) of (83.76) % which means that it has lost $83.76 on every $100 spent on asset. This is way below average. Similarly, it shows return on equity (ROE) of (9.0) % meaning that it generated substantial loss on money invested by shareholders.
The company has accumulated 4.34 M in total debt. Avivagen Inc has Current Ratio of 5.47 suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due.

Similar Executives

Showing few of many executives

DIRECTOR Since

V YoungRoyal Bank of Canada
1991
Guillermo BabatzThe Bank of Nova Scotia
2014
Thomas RenyiRoyal Bank of Canada
2013
Irene MillerThe Toronto Dominion Bank
2006
Paul SobeyThe Bank of Nova Scotia
1999
Michael PennerThe Bank of Nova Scotia
2017
Helen SinclairThe Toronto Dominion Bank
1996
Ashleigh EverettThe Bank of Nova Scotia
1997
J ReinhardRoyal Bank of Canada
2000
Richard GeorgeRoyal Bank of Canada
2012
Claude MongeauThe Toronto Dominion Bank
2015
Karen MaidmentThe Toronto Dominion Bank
2011
Susan SegalThe Bank of Nova Scotia
2011
Tiff MacklemThe Bank of Nova Scotia
2015
Heather MunroeBlumRoyal Bank of Canada
2011
Una PowerThe Bank of Nova Scotia
2016
William BeattieRoyal Bank of Canada
2001
John BraggThe Toronto Dominion Bank
2004
N EverettThe Bank of Nova Scotia
1997
Colleen GogginsThe Toronto Dominion Bank
2012
Mary HaddadThe Toronto Dominion Bank
2014

Entity Summary

Avivagen, Inc. develops and commercializes various solutions to replace antibiotics in livestock feeds to optimize the health and growth of the animals by supporting the animal?s own health defenses. Avivagen Inc (VIV) is traded on TSX Venture Exchange in Canada. It is located in Ottawa, ON KA R and employs 19 people.

Did you try this?

Run Fund Screener Now
   

Fund Screener

Find activelly-traded funds from around the world traded on over 30 global exchanges
Hide  View All  Next  Launch Fund Screener
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add Avivagen Inc to your portfolio

Top Management

Avivagen Inc Leadership Team
Amin Khalifa, Director
David Hankinson, Director
Cameron Groome, CEO
Louis Hui, Director
Vanessa Grant, Director
Andrew Basek, Director, MBA
Chris Boland, CFO
David Allan, Director
Drew Basek, Director, MBA
Paul Mesburis, Director
Graham Burton, Director, Ph.D
G Anthony, Director

Stock Performance

Avivagen Performance Indicators